MSLN and non-small cell lung carcinoma: Mesothelin is an immunogenic glycoprotein abundantly expressed in NSCLC and mesothelioma cells, with no appreciable expression in healthy tissue; it is correlated with a poor prognosis and resistance to chemotherapy [59].